High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study
Knud Schewe(Robert Koch Institute), Stephan Klauke(Infektionsmedizinisches Centrum Hamburg), Christoph D. Spinner(TUM Klinikum), Stefan Eßer(Essen University Hospital), Nils Postel, Christoph Wyen, Eva Wolf(MUC Research (Germany)), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Hans Jäger, Albrecht Stoehr, Markus Mueller(München Klinik Schwabing), Axel Baumgarten, Markus Bickel, Stefan Preis(Goethe University Frankfurt)
Cited by 17
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients
|Infection|2020|246
HIV-Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|220